Exclusive

Publication

Byline

Location

US Patent Issued to Eagle Pharmaceuticals on April 21 for "Methods of treating SARS-CoV-2 infections" (New Jersey Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,364, issued on April 21, was assigned to Eagle Pharmaceuticals Inc. (Woodcliff Lake, N.J.). "Methods of treating SARS-CoV-2 infections" wa... Read More


US Patent Issued to Scienture on April 21 for "Losartan liquid formulations and methods of use" (New York, New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,365, issued on April 21, was assigned to Scienture LLC (Commack, N.Y.). "Losartan liquid formulations and methods of use" was invented by ... Read More


US Patent Issued on April 21 for "Telmisartan for the treatment of hypertension in dogs" (Missouri, Georgia, Texas Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,366, issued on April 21. "Telmisartan for the treatment of hypertension in dogs" was invented by Anne Michelle Traas (Saint Joseph, Mo.), ... Read More


US Patent Issued on April 21 for "Methods of treatment and/or prevention of disorders and symptoms related to BKCa and/or SK channelophathies" (French Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,367, issued on April 21. "Methods of treatment and/or prevention of disorders and symptoms related to BKCa and/or SK channelophathies" was... Read More


US Patent Issued to Kyoto University on April 21 for "Suppression of neuroinflammation and composition and method therefor" (Japanese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,368, issued on April 21, was assigned to Kyoto University (Kyoto, Japan). "Suppression of neuroinflammation and composition and method the... Read More


US Patent Issued to Merck Sharp & Dohme on April 21 for "Amido-substituted heterocyclic compounds and methods of use thereof for the treatment of herpes viruses" (American, British Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,369, issued on April 21, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.). "Amido-substituted heterocyclic compounds and methods of ... Read More


US Patent Issued to University of Cincinnati on April 21 for "Agents and compositions for the treatment of glioblastoma" (Ohio Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,370, issued on April 21, was assigned to University of Cincinnati (Cincinnati). "Agents and compositions for the treatment of glioblastoma... Read More


US Patent Issued to The Board of Trustees of the Leland Stanford Junior University, The United States Governmment as represented by the Department of Veterans Affairs on April 21 for "Combination therapy for cancer" (California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,371, issued on April 21, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.) and The United S... Read More


US Patent Issued to Celgene on April 21 for "Combination therapy for the treatment of cancer" (New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,372, issued on April 21, was assigned to Celgene Corp. (Summit, N.J.). "Combination therapy for the treatment of cancer" was invented by M... Read More


US Patent Issued to Memorial Sloan Kettering Cancer Center, St. Jude Children's Research Hospital on April 21 for "Methods and compositions of inhibiting DCN1-UBC12 interaction" (Tennessee, New York, Arkansas Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,373, issued on April 21, was assigned to Memorial Sloan Kettering Cancer Center (New York) and St. Jude Children's Research Hospital Inc. (... Read More